Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€10.76
30.09.22
-
30.09.23
39.41%
03.10.22

Risky Investment
buy
Madrigal Pharmaceuticals inc.

Start price
Target price
Perf. (%)
€66.50
30.09.22
€120.00
31.12.24
324.36%
05.05.23

Could be very worthwhile Investment >20% year
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€13.70
30.09.22
€9.00
31.01.23
-12.08%
03.01.23

Could be very worthwhile Investment >20% year
buy
Apellis Pharmaceuticals

Start price
Target price
Perf. (%)
€69.48
29.09.22
€80.00
31.12.24
17.30%
05.05.23

Could be very worthwhile Investment >20% year
buy
scPharmaceuticals

Start price
Target price
Perf. (%)
€6.15
29.09.22
€8.00
31.12.24
-23.25%
10.10.22

Could be very worthwhile Investment >20% year
Prothena Corp. plc

Start price
Target price
Perf. (%)
€54.86
28.09.22
-
28.09.23
12.14%
01.10.22

Risky Investment
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.16
27.09.22
-
27.09.23
-4.31%
01.10.22

Risky Investment
buy
Syros Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.41
27.09.22
€11.60
27.09.23
8.69%
17.10.22

Could be very worthwhile Investment >20% year
Avenue Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.29
27.09.22
-
27.09.23
26.64%
01.10.22

Risky Investment
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€27.00
25.09.22
€16.00
31.12.24
57.78%
01.11.22

Could be very worthwhile Investment >20% year
buy
Intra-Cellular Therapies Inc.

Start price
Target price
Perf. (%)
€44.49
23.09.22
€80.00
31.07.25
28.12%
05.05.23

Could be very worthwhile Investment >20% year
buy
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€15.08
21.09.22
-
21.09.23
-4.44%
01.10.22

Risky Investment
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€2.05
20.09.22
€1.80
20.09.23
36.59%
19.11.22

Differentiated customer and product portfolio
Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Inovio Pharma

Start price
Target price
Perf. (%)
€1.88
20.09.22
€1.60
20.09.23
-7.46%
03.10.22

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
buy
Clovis Oncology Inc.

Start price
Target price
Perf. (%)
€1.17
20.09.22
-
20.09.23
-15.38%
15.10.22

Risky Investment
buy
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€16.65
20.09.22
€32.00
31.01.23
-17.72%
30.09.22

Could be very worthwhile Investment >20% year
buy
Minerva Neurosciences Inc.

Start price
Target price
Perf. (%)
€8.64
19.09.22
€17.00
19.09.23
-34.41%
17.10.22

Could be very worthwhile Investment >20% year
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.21
19.09.22
-
19.09.23
-12.19%
01.10.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
Vivani Medical Inc.

Start price
Target price
Perf. (%)
€2.81
19.09.22
-
19.09.23
-67.84%
24.04.23

Probably not worthwhile Investment
buy
Athersys Inc.

Start price
Target price
Perf. (%)
€1.87
19.09.22
€3.80
19.09.23
0.19%
17.10.22

Could be very worthwhile Investment >20% year
buy
Albireo Pharma Inc.

Start price
Target price
Perf. (%)
€16.96
18.09.22
-
18.09.23
144.16%
18.05.23

Risky Investment
buy
Intercept Pharmaceuticals

Start price
Target price
Perf. (%)
€17.43
18.09.22
-
18.09.23
-17.30%
01.10.22

Risky Investment
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€26.40
15.09.22
€8.00
15.09.23
-1.52%
17.09.22

Revenue growth >5% per year expected
Probably not worthwhile Investment
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Akero Therapeutics Inc

Start price
Target price
Perf. (%)
€26.40
15.09.22
€11.00
15.09.23
-1.52%
17.09.22

Differentiated customer and product portfolio
High valuation
High risks in the balance sheet
Increased challenges to pay loans and raise capital
buy
Athersys Inc.

Start price
Target price
Perf. (%)
€2.21
15.09.22
€4.60
15.09.23
-15.60%
19.09.22

Could be very worthwhile Investment >20% year